BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24080116)

  • 1. Burden of disease in treated rheumatoid arthritis patients: going beyond the joint.
    Cutolo M; Kitas GD; van Riel PL
    Semin Arthritis Rheum; 2014 Feb; 43(4):479-88. PubMed ID: 24080116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extra-articular manifestations of rheumatoid arthritis: An update.
    Prete M; Racanelli V; Digiglio L; Vacca A; Dammacco F; Perosa F
    Autoimmun Rev; 2011 Dec; 11(2):123-31. PubMed ID: 21939785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid arthritis in dermatology.
    Hata T; Kavanaugh A
    Clin Dermatol; 2006; 24(5):430-7. PubMed ID: 16966022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and patient-reported outcomes in clinical trials of abatacept in the treatment of rheumatoid arthritis.
    Massarotti EM
    Clin Ther; 2008 Mar; 30(3):429-42. PubMed ID: 18405783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extra-articular manifestations and complications of rheumatoid arthritis.
    Young A; Koduri G
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):907-27. PubMed ID: 17870035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-articular Manifestations and Comorbidity in Rheumatoid Arthritis: Potential Impact of Pre-Rheumatoid Arthritis Prevention.
    Giles JT
    Clin Ther; 2019 Jul; 41(7):1246-1255. PubMed ID: 31196641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis.
    Nyhäll-Wåhlin BM; Petersson IF; Nilsson JA; Jacobsson LT; Turesson C;
    Rheumatology (Oxford); 2009 Apr; 48(4):416-20. PubMed ID: 19213849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-articular rheumatoid arthritis.
    Turesson C
    Curr Opin Rheumatol; 2013 May; 25(3):360-6. PubMed ID: 23425964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
    Strand V; Singh JA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S237-51. PubMed ID: 18095787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for cardiovascular disease in rheumatoid arthritis.
    Gabriel SE; Crowson CS
    Curr Opin Rheumatol; 2012 Mar; 24(2):171-6. PubMed ID: 22249350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy.
    Capell H; McCarey D; Madhok R; Hampson R
    J Rheumatol; 2002 Oct; 29(10):2099-105. PubMed ID: 12375318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
    Avouac J; Allanore Y
    Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
    Strand V; Singh JA
    Am J Manag Care; 2008 Apr; 14(4):234-54. PubMed ID: 18415967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in early rheumatoid arthritis: impact of disease and treatment response.
    Kosinski M; Kujawski SC; Martin R; Wanke LA; Buatti MC; Ware JE; Perfetto EM
    Am J Manag Care; 2002 Mar; 8(3):231-40. PubMed ID: 11915973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The course of established rheumatoid arthritis.
    Scott DL; Steer S
    Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):943-67. PubMed ID: 17870037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe use of antirheumatic agents in patients with comorbidities.
    Makol A; Wright K; Matteson EL
    Rheum Dis Clin North Am; 2012 Nov; 38(4):771-93. PubMed ID: 23137582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of rheumatoid arthritis. Based on a presentation by Frederick Wolfe, MD.
    Am J Manag Care; 1999 Sep; 5(14 Suppl):S852-9; discussion S866-9. PubMed ID: 10621071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New drug discovery strategies for rheumatoid arthritis: a niche for nonhuman primate models to address systemic complications in inflammatory arthritis.
    Vierboom M; Breedveld E; 't Hart BA
    Expert Opin Drug Discov; 2012 Apr; 7(4):315-25. PubMed ID: 22458503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early local swelling and tenderness are associated with large-joint damage after 8 years of treatment to target in patients with recent-onset rheumatoid arthritis.
    van den Broek M; Dirven L; Kroon HM; Kloppenburg M; Ronday HK; Peeters AJ; Kerstens PJ; Huizinga TW; Lems WF; Allaart CF
    J Rheumatol; 2013 May; 40(5):624-9. PubMed ID: 23547212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.